NIH-funded research R21 grant

A new stent that uses wireless technology to help treat breathing problems caused by cilia dysfunction.

Official title: Wirelessly Actuated Ciliary Stent for Minimally Invasive Treatment of Cilia Dysfunction

Funded at Vanderbilt University · NIH-11140512 · Data updated 2026-11-12

This study is testing a new type of airway stent that uses tiny, moving parts to help clear mucus and improve breathing for people with COPD, making it easier and safer than current treatments.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startAugust 1, 2024
Project endApril 30, 2027
Funding year2025
Award (this year)$197,605
NIH project number5R21EB035200-02
Project IDNIH-11140512 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from Chronic Obstructive Pulmonary Disease (COPD) or other conditions that lead to airway obstruction and mucus accumulation.

Less likely to help

Patients with non-obstructive lung conditions or those who do not have issues related to cilia dysfunction may not benefit from this research.

What this research studies

This research aims to develop an innovative ciliary stent that incorporates wirelessly actuated artificial cilia to address cilia dysfunction, particularly in patients with Chronic Obstructive Pulmonary Disease (COPD). The stent is designed to support the airway and facilitate mucus transport, reducing the need for frequent bronchoscopy and minimizing the risks associated with traditional airway stents. By mimicking the natural movement of cilia, this device could improve airflow and reduce mucus buildup in the lungs, enhancing patient comfort and health. The approach is minimally invasive, utilizing a magnetic actuation system to control the cilia without the need for additional surgical procedures.

Why it matters

Potential benefit: If successful, this research could significantly improve breathing and quality of life for patients with airway obstruction due to cilia dysfunction.

How similar studies have gone: While the concept of using artificial cilia for medical applications is innovative, similar approaches have shown promise in preliminary studies, suggesting potential for success.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Dong, Xiaoguang — Vanderbilt University
  • Study coordinator: Dong, Xiaoguang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.